GO:2001240 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand: Dependence Receptor Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001240 describes the active suppression of extrinsic apoptosis when death ligands are absent, a process best known as dependence receptor signaling.
• Dependence receptors such as DCC, UNC5, and p75NTR induce apoptosis in the absence of their ligands, and their negative regulation prevents inappropriate cell death.
• Network pharmacology studies have identified natural compounds and decoctions that modulate apoptosis-related signaling, providing candidate regulators of this process.
• Loss of negative regulation of dependence receptor signaling contributes to cancer, neurodegeneration, and developmental disorders.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal role of genes in this pathway.
• High-throughput screening and bioinformatics can identify novel regulators of GO:2001240 for therapeutic targeting.
Description
The Gene Ontology term GO:2001240, negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, defines any process that stops, prevents, or reduces the frequency, rate, or extent of extrinsic apoptotic signaling when death ligands are not present. This term is synonymous with negative regulation of dependence receptor signaling pathway, a concept rooted in the biology of dependence receptors that actively trigger apoptosis in the absence of their ligands. Understanding this process is critical because it represents a safeguard against inappropriate cell survival or death, and its dysregulation is implicated in cancer, neurodegeneration, and developmental abnormalities. Researchers studying this term often focus on the molecular mechanisms by which dependence receptors are inhibited, including ligand-independent interactions, post-translational modifications, and downstream signaling crosstalk. Network pharmacology approaches have begun to uncover natural compounds that modulate these pathways, offering potential therapeutic entry points. This article synthesizes current knowledge on GO:2001240, covering its definition, key genes, regulatory mechanisms, disease relevance, and state-of-the-art research methods including CRISPR-based models.
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand At A Glance
| GO ID | GO:2001240 |
|---|---|
| GO term | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| Ontology | biological_process |
| Synonym | negative regulation of dependence receptor signaling pathway |
| Major function | Suppression of extrinsic apoptosis when death ligands are absent, often via dependence receptor inhibition |
| Related pathways | Dependence receptor signaling, extrinsic apoptotic pathway, caspase activation |
| Key regulators | DCC, UNC5, p75NTR, netrin-1, BDNF, and downstream effectors |
| Disease relevance | Cancer, neurodegeneration, developmental disorders |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, network pharmacology, RNA-seq, proteomics |
What Is GO:2001240?
GO:2001240 refers to any biological process that negatively regulates the extrinsic apoptotic signaling pathway when no ligand is present. In other words, it prevents cells from undergoing apoptosis through the extrinsic pathway under conditions where death ligands are absent. This term is closely associated with dependence receptor signaling, where receptors such as DCC or UNC5 induce apoptosis unless bound by their ligands; negative regulation of this pathway ensures that cells survive when appropriate. The definition encompasses molecular events that inhibit pro-apoptotic signaling from dependence receptors, including protein-protein interactions, cleavage events, and downstream pathway modulation.
Why Is negative regulation of extrinsic apoptotic signaling pathway in absence of ligand Important in Cell Biology?
GO:2001240 is important because it governs a fundamental cell-fate decision: whether a cell survives or dies when death ligands are absent. Dependence receptors such as DCC and UNC5 are known to induce apoptosis in the absence of their ligands, and negative regulation of this process is essential for normal development and tissue homeostasis. Dysregulation of this pathway can lead to cancer, where cells evade apoptosis, or neurodegeneration, where excessive cell death occurs. Moreover, natural compounds and pharmacological agents that modulate this pathway have been identified through network pharmacology, highlighting its therapeutic potential. Understanding the molecular players and regulatory mechanisms of GO:2001240 is therefore critical for developing targeted interventions in oncology and neurology.
• Prevents inappropriate apoptosis in the absence of death ligands, maintaining cell survival.
• Dependence receptors like DCC and UNC5 are central to this process, and their negative regulation is crucial for development.
• Loss of negative regulation can contribute to tumorigenesis by allowing cells to survive despite pro-apoptotic signals.
• Excessive negative regulation may promote neurodegeneration by blocking necessary cell death.
• Natural compounds such as resveratrol and Coix seed decoction have been shown to modulate apoptosis-related pathways, offering therapeutic leads.
• Network pharmacology is a powerful approach to identify regulators of this pathway.
• CRISPR-based models enable precise dissection of gene function in this pathway.
• Understanding this term aids in the development of targeted therapies for cancer and neurological disorders.
• It is a key component of the extrinsic apoptotic pathway, complementing intrinsic apoptosis regulation.
• Research on GO:2001240 can reveal biomarkers for disease prognosis and treatment response.
What Happens During negative regulation of extrinsic apoptotic signaling pathway in absence of ligand?
Dependence Receptor Activation in the Absence of Ligand
In simple terms: When a dependence receptor does not bind its ligand, it sends a signal for the cell to die.
Dependence receptors such as DCC, UNC5, and p75NTR are transmembrane proteins that induce apoptosis when their ligands are absent. In the absence of netrin-1, DCC and UNC5 receptors undergo conformational changes that expose pro-apoptotic domains, leading to caspase activation and cell death. This ligand-independent pro-apoptotic signaling is the default state that negative regulation must overcome.
Ligand-Independent Inhibition of Pro-Apoptotic Signaling
In simple terms: Negative regulation stops the death signal even when no ligand is present.
Negative regulation of dependence receptor signaling can occur through protein-protein interactions that mask pro-apoptotic domains, post-translational modifications that inhibit receptor activity, or downstream effectors that block caspase activation. For example, binding of netrin-1 to DCC or UNC5 receptors inhibits their pro-apoptotic function, but in the absence of ligand, other proteins may compensate to suppress apoptosis. Network pharmacology studies have identified natural compounds that may enhance or inhibit these interactions.
Downstream Caspase Cascade Suppression
In simple terms: The cell's death executioners, caspases, are kept in check.
Extrinsic apoptosis in the absence of ligand often converges on caspase-8 and caspase-3 activation. Negative regulation of this pathway involves inhibitors of apoptosis (IAPs), FLIP proteins, or other modulators that prevent caspase processing and activation. Resveratrol, for instance, has been shown to modulate apoptosis-related proteins in osteoblastic cells, suggesting a potential role in regulating caspase activity.
Crosstalk with Intrinsic Apoptotic Pathway
In simple terms: The decision to die involves both external and internal signals.
Negative regulation of extrinsic apoptosis in the absence of ligand can also involve crosstalk with the intrinsic apoptotic pathway. Proteins such as Bcl-2 family members may be modulated to prevent mitochondrial outer membrane permeabilization, thereby blocking amplification of the death signal. This integration ensures that cells survive only when multiple pro-survival signals are present.
Regulation by Pharmacological and Natural Compounds
In simple terms: Certain drugs and natural products can tweak this survival-death balance.
Network pharmacology analyses have revealed that compounds like those in Coix seed decoction and resveratrol can affect apoptosis-related signaling networks. These compounds may act by modulating the expression or activity of dependence receptors and downstream effectors, thereby influencing GO:2001240. Such findings provide a basis for developing therapeutics that target this pathway.
Key Genes Involved in GO:2001240 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
The following genes and proteins are central to the negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, based on their roles in dependence receptor signaling and apoptosis modulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DCC | Dependence receptor; induces apoptosis in absence of netrin-1 | Key model for studying ligand-independent apoptosis |
| UNC5A | Dependence receptor; pro-apoptotic when unbound | Target for negative regulation studies |
| UNC5B | Dependence receptor; mediates apoptosis without netrin-1 | Involved in vascular and neural development |
| UNC5C | Dependence receptor; pro-apoptotic signaling | Implicated in colorectal cancer |
| UNC5D | Dependence receptor; apoptosis induction | Potential tumor suppressor |
| p75NTR | Dependence receptor; induces apoptosis in absence of neurotrophins | Role in neurodegeneration |
| NTN1 | Ligand for DCC/UNC5; inhibits pro-apoptotic signaling | Therapeutic target to block apoptosis |
| BDNF | Ligand for p75NTR; promotes survival | Neuroprotection studies |
| CASP8 | Initiator caspase in extrinsic apoptosis | Effector of dependence receptor signaling |
| CASP3 | Executioner caspase | Downstream apoptosis marker |
| CFLAR | FLIP; inhibits caspase-8 activation | Negative regulator of extrinsic apoptosis |
| BIRC2 | cIAP1; inhibits caspases | Modulator of apoptosis |
| BIRC3 | cIAP2; inhibits caspases | Modulator of apoptosis |
| BCL2 | Anti-apoptotic; blocks intrinsic pathway | Crosstalk with extrinsic pathway |
| BAX | Pro-apoptotic; promotes intrinsic apoptosis | Crosstalk with extrinsic pathway |
| TP53 | Tumor suppressor; regulates apoptosis | Upstream regulator of dependence receptor pathways |
| AKT1 | Survival kinase; inhibits apoptosis | Negative regulator of extrinsic apoptosis |
How Is negative regulation of extrinsic apoptotic signaling pathway in absence of ligand Regulated?
The negative regulation of extrinsic apoptotic signaling pathway in absence of ligand is itself tightly regulated. Key regulatory mechanisms include ligand binding to dependence receptors, which switches them from pro-apoptotic to pro-survival signaling. Post-translational modifications such as phosphorylation, ubiquitination, and proteolytic cleavage can modulate receptor activity and downstream caspase activation. For example, AKT-mediated phosphorylation can inhibit pro-apoptotic proteins, thereby promoting survival. Additionally, crosstalk with the intrinsic apoptotic pathway via Bcl-2 family proteins can amplify or dampen the death signal. Network pharmacology studies have identified natural compounds that may regulate these processes, suggesting that pharmacological modulation is feasible.
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DCC | Colorectal cancer, neural development | Knockout and point mutation in HCT116 cells |
| UNC5C | Colorectal cancer, neurodegeneration | Overexpression and knockout in neuronal cells |
| p75NTR | Alzheimer's disease, neuronal apoptosis | Knock-in of disease-associated variants in iPSCs |
| NTN1 | Cancer, neuroprotection | Overexpression in tumor cell lines |
| CASP8 | Apoptosis resistance in cancer | Point mutation to inhibit catalytic activity |
Cancer
Dysregulation of dependence receptor signaling is implicated in cancer. Loss of pro-apoptotic function of DCC or UNC5 receptors, or overexpression of their ligands, can lead to uncontrolled cell survival and tumorigenesis. Negative regulation of extrinsic apoptosis in the absence of ligand may contribute to chemoresistance, making this pathway a target for anticancer therapy. Network pharmacology studies have identified compounds that modulate apoptosis-related networks, offering potential therapeutic strategies.
Neurodegeneration
In neurodegenerative diseases, excessive negative regulation of dependence receptor signaling may prevent necessary apoptosis, or conversely, loss of negative regulation may lead to excessive cell death. p75NTR, a dependence receptor, has been implicated in neuronal death in conditions such as Alzheimer's disease and amyotrophic lateral sclerosis. Modulating this pathway could be neuroprotective.
Developmental Disorders
Dependence receptors play critical roles in development, guiding axon pruning and tissue morphogenesis. Disruption of negative regulation of extrinsic apoptosis in the absence of ligand can lead to developmental abnormalities, including defects in neural tube closure and organogenesis. Understanding these mechanisms is essential for developmental biology.
Osteoarthritis
Network pharmacology analysis of Coix seed decoction for osteoarthritis identified apoptosis-related pathways as key targets. This suggests that modulation of extrinsic apoptotic signaling in the absence of ligand may influence chondrocyte survival and joint degeneration. Further research could reveal new therapeutic avenues.
From negative regulation of extrinsic apoptotic signaling pathway in absence of ligand-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate dependence receptor-induced apoptosis? | CRISPR knockout in cell lines (e.g., HEK293, HCT116) |
| Does a specific point mutation in gene Y alter its anti-apoptotic function? | Point mutation knock-in via CRISPR |
| How does tagging gene Z affect its localization during apoptosis? | Knock-in of fluorescent tag (e.g., GFP) |
| Does overexpression of gene W protect against ligand-independent apoptosis? | Overexpression via lentiviral transduction |
| What is the role of gene V in osteoarthritis-related apoptosis? | CRISPR knockout in chondrocytes |
| Can natural compounds modulate gene U expression? | Network pharmacology and experimental validation |
How to Study the negative regulation of extrinsic apoptotic signaling pathway in absence of ligand Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for survival in absence of ligand | Identify negative regulators of apoptosis |
| RNA-seq | Transcriptional changes | Discover differentially expressed genes in dependence receptor signaling |
| Proteomics | Protein abundance and interactions | Map protein complexes in apoptosis regulation |
| Phosphoproteomics | Phosphorylation events | Identify signaling pathways that inhibit apoptosis |
| Flow cytometry | Apoptotic cell percentage | Quantify cell death after genetic manipulation |
| Caspase activity assay | Caspase-3/8 activity | Measure extrinsic apoptosis activation |
| Live-cell imaging | Real-time apoptosis dynamics | Visualize caspase activation in single cells |
| Network pharmacology | Compound-target interactions | Predict natural compounds modulating apoptosis |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that negatively regulate extrinsic apoptosis in the absence of ligand. Cells are treated with inducers of dependence receptor signaling (e.g., ligand withdrawal) and sgRNA libraries are used to select for survival or death. Hits are validated by individual knockout and rescue experiments.
RNA Sequencing and Transcriptomics
RNA-seq can reveal transcriptional changes in dependence receptors, caspases, and anti-apoptotic genes under conditions of ligand absence. Differential expression analysis identifies candidate regulators of GO:2001240. This approach is often combined with network pharmacology to pinpoint pathways.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify protein interactions and post-translational modifications of dependence receptors and downstream effectors. Phosphoproteomics identifies signaling events that inhibit or promote apoptosis in the absence of ligand.
Apoptosis Assays and Imaging
Flow cytometry with Annexin V/PI staining, caspase activity assays, and live-cell imaging of fluorescent reporters (e.g., caspase-3 biosensors) are used to measure apoptosis rates. These methods validate the functional impact of genetic perturbations.
How CRISPR Can Be Used to Study GO:2001240 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
Knockout
CRISPR knockout of candidate genes (e.g., DCC, UNC5C, CASP8) can determine whether they are required for negative regulation of extrinsic apoptosis in the absence of ligand. Cells with gene knockouts are challenged with ligand withdrawal or dependence receptor activation, and apoptosis is measured. Loss of a negative regulator should increase apoptosis.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to abrogate specific domains (e.g., catalytic dead caspase-8). These models help dissect the precise molecular mechanisms by which a gene regulates apoptosis in the absence of ligand.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags allows real-time tracking of protein localization and interactions during apoptosis. Knock-in of disease-relevant mutations can model human disorders in isogenic cell lines.
Overexpression
Overexpression of candidate genes (e.g., BCL2, CFLAR) via lentiviral vectors can test whether increased levels protect against ligand-independent apoptosis. This approach is useful for validating gain-of-function mechanisms.
How EDITGENE Supports negative regulation of extrinsic apoptotic signaling pathway in absence of ligand Research
Researchers studying negative regulation of extrinsic apoptotic signaling pathway in absence of ligand-related genes often need to determine whether a candidate gene is causally involved in preventing apoptosis when death ligands are absent. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of extrinsic apoptotic signaling pathway in absence of ligand research.
Frequently Asked Questions About negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
What is GO:2001240?
GO:2001240 is a Gene Ontology term for any process that negatively regulates the extrinsic apoptotic signaling pathway when no ligand is present, often involving dependence receptor signaling.
What genes are involved in negative regulation of extrinsic apoptotic signaling pathway in absence of ligand?
Key genes include DCC, UNC5 family members, p75NTR, CASP8, CFLAR, and BCL2, among others.
How does dependence receptor signaling relate to GO:2001240?
Dependence receptors induce apoptosis in the absence of their ligands; negative regulation of this signaling prevents inappropriate cell death, which is the essence of GO:2001240.
What diseases are associated with dysregulation of this pathway?
Cancer, neurodegeneration, developmental disorders, and osteoarthritis have been linked to dysregulation of this pathway.
What research methods are used to study GO:2001240?
CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, and network pharmacology are commonly used.
How can CRISPR help study negative regulation of extrinsic apoptosis?
CRISPR enables precise genetic perturbations to test the causal role of specific genes in preventing apoptosis in the absence of ligand.
What is the role of netrin-1 in this pathway?
Netrin-1 binding to DCC or UNC5 receptors inhibits their pro-apoptotic function, thus negatively regulating extrinsic apoptosis.
Can natural compounds modulate GO:2001240?
Yes, network pharmacology studies suggest that compounds like resveratrol and Coix seed decoction components can modulate apoptosis-related pathways.
What cell models are suitable for studying this pathway?
HEK293, HCT116, neuronal cell lines, and chondrocytes are commonly used, with genetic modifications via CRISPR.
How does EDITGENE support research on GO:2001240?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to this pathway.
Conclusion
GO:2001240, negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, is a critical biological process that governs cell survival when death ligands are absent. Its dysregulation is implicated in cancer, neurodegeneration, and developmental disorders, making it a promising therapeutic target. Advances in CRISPR-based models and network pharmacology are accelerating the discovery of key regulators and potential drugs. Continued research into this pathway will deepen our understanding of cell-fate decisions and open new avenues for treatment.
References
- 1. Qiu J et al.. 2023. Network pharmacological analysis on the mechanism of Coix seed decoction for osteoarthritis of the knee.. Medicine (Baltimore) 102(31):e34464 PMID: 37543793
- 2. He Y et al.. 2024. Molecular mechanism of resveratrol promoting differentiation of preosteoblastic MC3T3-E1 cells based on network pharmacology and experimental validation.. BMC Complement Med Ther 24(1):108 PMID: 38424533
